Recombinant interleukin-2 in metastatic renal-cell carcinoma - a European multicenter phase-II study
Authors
Vondermaase, HGeertsen, P
Thatcher, Nick
Jasmin, C
Mercatello, A
Fossa, S D
Symann, M
Stoter, G
Nagel, G
Israel, L
Oskam, R
Palmer, P
Franks, C R
Affiliation
Department of Oncology, Herlev University Hospital, Copenhagen, Denmark.Issue Date
1991
Metadata
Show full item recordCitation
Recombinant interleukin-2 in metastatic renal-cell carcinoma - a European multicenter phase-II study. 1991, 27(12) : 1583-1589 Eur J CancerJournal
European Journal of CancerPubMed ID
1782066Type
ArticleLanguage
enCollections
Related articles
- Treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2: a single-center phase II study.
- Authors: Geertsen PF, Hermann GG, von der Maase H, Steven K
- Issue date: 1992 May
- Phase II trial of high-dose intermittent interleukin-2 in metastatic renal cell carcinoma: a Southwest Oncology Group study.
- Authors: Bukowski RM, Goodman P, Crawford ED, Sergi JS, Redman BG, Whitehead RP
- Issue date: 1990 Jan 17
- A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspects.
- Authors: Vlasveld LT, Rankin EM, Hekman A, Rodenhuis S, Beijnen JH, Hilton AM, Dubbelman AC, Vyth-Dreese FA, Melief CJ
- Issue date: 1992 May
- Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of a European multicentre study.
- Authors: Negrier S, Philip T, Stoter G, Fossa SD, Janssen S, Iacone A, Cleton FS, Eremin O, Israel L, Jasmin C
- Issue date: 1989
- A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma.
- Authors: Weiss GR, Margolin KA, Aronson FR, Sznol M, Atkins MB, Dutcher JP, Gaynor ER, Boldt DH, Doroshow JH, Bar MH
- Issue date: 1992 Feb